Literature DB >> 27614887

Parents as source of pertussis transmission in hospitalized young infants.

Giorgio Fedele1, Maria Carollo2, Raffaella Palazzo2, Paola Stefanelli2, Elisabetta Pandolfi3, Francesco Gesualdo3, Alberto Eugenio Tozzi3, Rita Carsetti4, Alberto Villani5, Ambra Nicolai6, Fabio Midulla6, Clara Maria Ausiello2.   

Abstract

PURPOSE: This study was planned to collect evidences of familial pertussis transmission to infants younger than 6 months of age. Understanding the dynamics of transmission of pertussis in families is essential to plan effective prevention strategies that could be integrated in pertussis control.
METHODS: The seroprevalence of IgG antibodies to pertussis toxin (PT-IgG) and prolonged cough symptoms were evaluated in parents of 55 infants aged <6 months hospitalized for confirmed pertussis. Parents of 33 infants with lower respiratory tract infection (LRTI) and parents of 57 healthy infants admitted as outpatients for hip ultrasound examination (HE) were enrolled as controls.
RESULTS: Parents of pertussis cases had PT-IgG levels significantly higher as compared to LRTI and HE parents. More than 40 % were compatible as transmitters of pertussis to their babies, since they had a level of PT-IgG ≥ 100 IU/ml, which is considered diagnostic for a recent pertussis episode. Based on serology, the percentage of pertussis cases that had at least one parent as source of infection was 49.1 %. When cough symptoms were taken into account, the percentage of parents putative transmitters of the infection to their infants increased to 56.4 %.
CONCLUSIONS: Parents are scarcely aware of the household transmission of pertussis to their newborns. Our study highlights the need to advise parents about the likelihood of transmission to the newborn and to be particularly aware of coughing symptoms in the household. Since infection can be asymptomatic, a serological survey of family members should also be considered.

Entities:  

Keywords:  Infant; Pertussis; Serology; Source of infection

Mesh:

Substances:

Year:  2016        PMID: 27614887     DOI: 10.1007/s15010-016-0943-6

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  32 in total

Review 1.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

Review 2.  Diagnosis and management of pertussis.

Authors:  Alberto E Tozzi; Lucia Pastore Celentano; Marta Luisa Ciofi degli Atti; Stefania Salmaso
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

3.  Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.

Authors:  Hans O Hallander; Margaretha Ljungman; Jann Storsaeter; Lennart Gustafsson
Journal:  APMIS       Date:  2009-11       Impact factor: 3.205

4.  Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

Authors:  Joel I Ward; James D Cherry; Swei-Ju Chang; Susan Partridge; Wendy Keitel; Kathryn Edwards; Martin Lee; John Treanor; David P Greenberg; Stephen Barenkamp; David I Bernstein; Robert Edelman
Journal:  Clin Infect Dis       Date:  2006-06-05       Impact factor: 9.079

5.  Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.

Authors:  Dorothy Xing; Carl Heinz Wirsing von König; Penny Newland; Marion Riffelmann; Bruce D Meade; Michael Corbel; Rose Gaines-Das
Journal:  Clin Vaccine Immunol       Date:  2008-12-24

Review 6.  Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization.

Authors:  Anita H J van den Biggelaar; Jan T Poolman
Journal:  Expert Rev Vaccines       Date:  2015-11-11       Impact factor: 5.217

7.  Childhood vaccination coverage in Italy: results of a seven-region survey. The Italian Vaccine Coverage Survey Working Group.

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

8.  Infant pertussis: who was the source?

Authors:  Kristine M Bisgard; F Brian Pascual; Kristen R Ehresmann; Claudia A Miller; Christy Cianfrini; Charles E Jennings; Catherine A Rebmann; Julie Gabel; Stephanie L Schauer; Susan M Lett
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129

Review 9.  What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories.

Authors:  N Guiso; G Berbers; N K Fry; Q He; M Riffelmann; C H Wirsing von König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-11       Impact factor: 3.267

10.  Asymptomatic transmission and the resurgence of Bordetella pertussis.

Authors:  Benjamin M Althouse; Samuel V Scarpino
Journal:  BMC Med       Date:  2015-06-24       Impact factor: 8.775

View more
  10 in total

1.  Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.

Authors:  Ricardo da Silva Antunes; Mariana Babor; Chelsea Carpenter; Natalie Khalil; Mario Cortese; Alexander J Mentzer; Grégory Seumois; Christopher D Petro; Lisa A Purcell; Pandurangan Vijayanand; Shane Crotty; Bali Pulendran; Bjoern Peters; Alessandro Sette
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

2.  Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts.

Authors:  A Orsi; C Azzari; E Bozzola; G Chiamenti; G Chirico; S Esposito; F Francia; P Lopalco; R Prato; R Russo; A Villani; E Franco
Journal:  J Prev Med Hyg       Date:  2018-06-01

3.  Severe pertussis infection in infants less than 6 months of age: Clinical manifestations and molecular characterization.

Authors:  Paola Stefanelli; Gabriele Buttinelli; Paola Vacca; Alberto E Tozzi; Fabio Midulla; Rita Carsetti; Giorgio Fedele; Alberto Villani; Carlo Concato
Journal:  Hum Vaccin Immunother       Date:  2017-01-27       Impact factor: 3.452

4.  Pertussis immunization in healthcare workers working in pediatric settings: Knowledge, Attitudes and Practices (KAP) of Occupational Physicians. Preliminary results from a web-based survey (2017).

Authors:  M RICCò; L Vezzosi; G Gualerzi; N L Bragazzi; F Balzarini
Journal:  J Prev Med Hyg       Date:  2020-04-02

5.  Prevention of pertussis: from clinical trials to Real World Evidence.

Authors:  S Esposito
Journal:  J Prev Med Hyg       Date:  2018-09-28

6.  Analysis of clinical characteristics of severe pertussis in infants and children: a retrospective study.

Authors:  Caiying Wang; Huimin Zhang; Yanlan Zhang; Lin Xu; Min Miao; Hongling Yang; Yuhuan Liu; Shuxin He; Lin Pang
Journal:  BMC Pediatr       Date:  2021-02-05       Impact factor: 2.125

7.  Clinical characteristics of 967 children with pertussis: a single-center analysis over an 8-year period in Beijing, China.

Authors:  Limin Kang; Xiaodai Cui; Jin Fu; Wenpeng Wang; Li Li; Tiegeng Li; Xiaoying Wang; Fei Xiao; Huixue Jia; Rong Mi; Xinlin Hou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-08-16       Impact factor: 3.267

8.  Protection against Pertussis in Humans Correlates to Elevated Serum Antibodies and Memory B Cells.

Authors:  Valentina Marcellini; Eva Piano Mortari; Giorgio Fedele; Francesco Gesualdo; Elisabetta Pandolfi; Fabio Midulla; Pasqualina Leone; Paola Stefanelli; Alberto Eugenio Tozzi; Rita Carsetti
Journal:  Front Immunol       Date:  2017-09-15       Impact factor: 7.561

9.  Pertussis in Italy: how to protect the "unprotectable"?

Authors:  Fabiana Fiasca; Stefano Necozione; Antonella Mattei
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

10.  Experience and attitudes on vaccinations recommended during pregnancy: survey on an Italian sample of women and consultant gynecologists.

Authors:  Maria Scatigna; Alessandro Appetiti; Mariachiara Pasanisi; Silvia D'Eugenio; Leila Fabiani; Anna Rita Giuliani
Journal:  Hum Vaccin Immunother       Date:  2021-05-06       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.